Purchase Order 75N93025P01071

Award Date 8/28/25
Potential Completion Date 8/27/26
Potential Value $250K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. The $24,800 contract is for the provision of various Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis. No set-aside designations are noted. Illumina has previously received prime contracts and subcontracts from other federal...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract, valued at $12,875.00, is for sequencing services to support NIAID's research and diagnostic efforts. Illumina has previously been awarded other prime federal contracts and subcontracts by...
This is a $189,332.15 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis instruments and reagents. The contract provides an annual service agreement for four Illumina sequencing instruments, including preventative maintenance, parts, labor, reagent replacement, and technical...
This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents. The $48,632 award provides Illumina sequencing instruments, consumables, and services to support genomic research and diagnostics. Illumina has a history of prime contracts and subcontracts with various federal agencies for similar products and services, including the...
This is a firm fixed price Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. for $15,564.92. The contract provides Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic purposes. No set-aside designation was used. Illumina has previously received prime contract awards from agencies like the...
This is a $19,812.90 firm fixed-price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related products. The contract has an ultimate completion date of August 3, 2026 and was awarded on August 4, 2025. No set-aside designation was used. Illumina, a leading provider of DNA and RNA sequencing technologies, will deliver a range...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Illumina, Inc. The $5,006.36 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related services and support to support genomic sequencing and analysis, with no set-aside designation. Illumina is a manufacturer of genetic and genomic analysis instruments and solutions, and...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $3,161.60 and is for the provision of Illumina's sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic applications. The contract does not have a set-aside designation. Based on Illumina's history...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $3,409.10 contract is for the provision of sequencing systems, reagents, consumables, and related support services to support genomic research and diagnostics. Illumina has a history of prior prime federal contract and...
This is a $68,929.06 firm fixed price delivery order awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is for the provision of various Illumina sequencing systems, reagents, consumables, and support services to support genomic sequencing and analysis for research and diagnostic purposes. Illumina has previously received prime federal contract and subcontract awards from...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic analysis technologies. The $249,519.59 contract is for a service agreement to provide multiple Illumina DNA sequencers over a 1-year period from August 28, 2025 to August 27, 2026. The contract does not utilize a set-aside designation. Illumina is a key technology provider for federal scientific and diagnostic research initiatives, having been awarded prime contracts and Indefinite Delivery Vehicles (IDVs) from various agencies including the USDA and VA. This contract supports NIAID's research efforts in areas such as infectious disease, leveraging Illumina's advanced DNA and RNA sequencing platforms, reagents, and bioinformatics capabilities.

Generated 8/27/25, 9:47 AM